52,844 Shares in Omada Health, Inc. $OMDA Bought by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. bought a new stake in shares of Omada Health, Inc. (NASDAQ:OMDA) in the 3rd quarter, HoldingsChannel reports. The firm bought 52,844 shares of the company’s stock, valued at approximately $1,100,000.

Other hedge funds have also bought and sold shares of the company. Versant Capital Management Inc grew its stake in Omada Health by 319.3% in the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock worth $66,000 after buying an additional 2,283 shares in the last quarter. Integrated Wealth Concepts LLC purchased a new stake in shares of Omada Health during the 2nd quarter valued at $53,000. State of Alaska Department of Revenue purchased a new stake in shares of Omada Health during the 3rd quarter valued at $59,000. Legal & General Group Plc bought a new stake in shares of Omada Health during the 2nd quarter worth $76,000. Finally, The Manufacturers Life Insurance Company bought a new stake in shares of Omada Health during the 2nd quarter worth $215,000.

Insider Buying and Selling at Omada Health

In related news, CEO Sean Duffy sold 17,258 shares of the stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $20.68, for a total transaction of $356,895.44. Following the transaction, the chief executive officer owned 382,594 shares of the company’s stock, valued at approximately $7,912,043.92. This trade represents a 4.32% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, President Wei-Li Shao sold 4,036 shares of Omada Health stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $21.85, for a total transaction of $88,186.60. Following the completion of the transaction, the president owned 295,313 shares in the company, valued at approximately $6,452,589.05. The trade was a 1.35% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 127,642 shares of company stock worth $2,915,201 over the last 90 days. Company insiders own 6.38% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on OMDA. Citizens Jmp upped their target price on shares of Omada Health from $27.00 to $32.00 and gave the stock a “market outperform” rating in a research report on Friday, August 14th. Needham & Company LLC restated a “buy” rating and set a $28.00 price target on shares of Omada Health in a research report on Friday, September 11th. Wall Street Zen raised Omada Health from a “hold” rating to a “buy” rating in a research note on Sunday, October 11th. Barclays lifted their price target on Omada Health from $25.00 to $27.00 and gave the stock an “overweight” rating in a research note on Friday, September 11th. Finally, BTIG Research reiterated a “buy” rating and issued a $35.00 price objective on shares of Omada Health in a report on Friday, September 11th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $26.67.

Omada Health Price Performance

Shares of NASDAQ OMDA opened at $19.24 on Tuesday. Omada Health, Inc. has a one year low of $10.28 and a one year high of $26.92. The firm’s 50 day simple moving average is $21.13 and its two-hundred day simple moving average is $17.63. The stock has a market capitalization of $1.18 billion, a P/E ratio of 236.88 and a beta of 2.03.

Omada Health (NASDAQ:OMDA) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.08 EPS for the quarter, topping the consensus estimate of ($0.02) by $0.10. The firm had revenue of $87.83 million for the quarter, compared to the consensus estimate of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. As a group, equities analysts expect that Omada Health, Inc. will post 0.09 earnings per share for the current fiscal year.

Omada Health Profile

Omada Health, Inc (NASDAQ: OMDA) is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines personalized health coaching, clinical support, behavioral-change tools and connected devices to help members monitor and improve their health.

The company’s offerings focus primarily on cardiometabolic conditions, including diabetes, prediabetes, hypertension and obesity, as well as musculoskeletal conditions. Depending on the program, members may receive access to digital lessons, health tracking, remote monitoring, care teams and clinical guidance through Omada’s technology platform.

Omada Health was founded in 2011 and serves employers, health plans and other healthcare organizations in the United States.